Follow-up testing for metabolic diseases identified by expanded newborn screening using tandem mass spectrometry. National Academy of Clinical Biochemistry. NGC:007158

Publication Details

Author(s):

• AHRQ (US) - Agency for Healthcare Research and Quality

Country(ies) of application:

• United States

Language(s):

• English

Type of Publication:

Guideline Clearing Report

Primary Contact:

Jean R. Slutsky, P.A., M.S.P.H.
jslutsky@ahrq.gov

Publication URL:

Open Publication URL in a new window

Publication Scope:

• Prevention
• Screening

Publication Status:

Published

Date of publication:

Jan 01, 2009

Due for Review:

-

Diseases / Conditions Addressed

MeSH Terms addressed:

• Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)
  • Infant, Newborn, Diseases (C16.614)
  • Genetic Diseases, Inborn (C16.320)
• Diagnosis (E01)
  • Diagnostic Techniques and Procedures (E01.370)
• Nutritional and Metabolic Diseases (C18)
  • Metabolic Diseases (C18.452)
• Biochemical Phenomena, Metabolism, and Nutrition (G06)
  • Metabolism (G06.535)
• Pediatrics (G02.403.776.610)
• Public Health (N06.850)
  • Public Health Practice (N06.850.780)
    • Mass Screening (N06.850.780.500)

Guideline key questions